Shanghai Fosun Pharma Announces Board Structure

Shanghai Fosun Pharmaceutical (Group) Co (HK:2196) has released an update.

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. has announced the composition of its board of directors, which consists of 12 members including executive, non-executive, and independent directors. The company has also detailed the membership of its five key committees, such as the Strategic Committee, Audit Committee, and others, indicating the roles and involvement of each board member within these committees.

For further insights into HK:2196 stock, check out TipRanks’ Stock Analysis page.